Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11866406 Compositions of trofinetide

Patent 11866406 was granted and assigned to Neuren Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Neuren Pharmaceuticals

0

Current Assignee

Neuren Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

James Murray Shaw0

Cecilia Betti0

Mimoun Ayoub0

James Anthony Bonnar0

Clive Blower0

Martin Bernard Catherine Bousmanne0

Karel Willy Luc Decroos0

Mathew Peterson0

...

Date of Patent

January 9, 2024

0

Patent Application Number

178477360

Date Filed

June 23, 2022

0

Patent Citations

US Patent 8178125 Oral formulations of glycyl-2-methylprolyl-glutamate

0

US Patent 8496963 Oral formulations of glycyl-2-methylprolyl-glutamate

0

US Patent 8546530 Process for the manufacture of persilylated peptides

0

US Patent 8637567 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid

0

US Patent 9212204 Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid

0

US Patent 11370755 Compositions of trofinetide

0

US Patent 9708366 Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate

0

US Patent 7041314 GPE analogs and peptidominetics

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866406 Compositions of trofinetide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool